Treatment of fibromyalgia (Fibrositis syndrome): A parallel double blind trial with carisoprodol,paracetamol and caffeïne (Somadril comp®) versus placebo

Summary Forty-three of fifty-eight (74.1%) female patients with fibromyalgia completed an eight-week treatment period testing the combination of carisoprodol, paracetamol (acetaminophen) and caffeine versus placebo. Twenty-three patients received placebo and twenty active medication. In the placebo group 56.5% of the patients used additional analgesics or nonsteroidal anti-inflammatory drugs compared to only 20% in the active treatment group (p=0.015). Forty-three percent of the patients in the placebo group and none of the patients in the active treatment group used tricyclic antidepressants, anxiolytics or sedatives (p=0.0008). Active treatment gave statistically significant improvement after treatment for pain (p<0.01), for sleep quality (p<0.01) and for the general feeling of sickness (p<0.05). In the active treatment group increased pressure pain threshold after eight weeks was found at 70% of the sites measured, while the pressure pain threshold was increased at only 30% of the sites in the placebo group. In the placebo group improvement was found for the pain and sleep quality (p<0.05). This improvement may in part be due to the large amounts of extra medication in this group. Thus, the combination of carisoprodol and paracetamol (acetaminophen) and caffeine are effective in the treatment of fibromyalgia.     

酮康唑联合克霉唑栓治疗老年念珠菌性阴道炎的临床疗效及其安全性

目的探讨酮康唑联合克霉唑栓治疗老年念珠菌性阴道炎的临床疗效及其安全性。方法选取南昌县中医院2017年1月-2019年1月收治的老年念珠菌性阴道炎患者50例,根据单盲分组法分成参照组与研究组,各25例。参照组予以酮康唑治疗,研究组在参照组基础上联合克霉唑栓治疗。两组均治疗9 d。比较两组临床疗效,并观察两组不良反应发生情况。结果研究组治疗总有效率高于参照组,不良反应发生率低于参照组(P<0.05)。结论酮康唑联合克霉唑栓治疗老年念珠菌性阴道炎的临床疗效确切,可有效改善患者临床症状与体征,且安全性较高。     

重组人干扰素α-2b栓联合物理治疗宫颈上皮内瘤变Ⅰ级合并高危HPV阳性疗效观察

目的分析重组人干扰素α-2b栓联合物理治疗合并高危人乳头瘤病毒(HPV)阳性宫颈上皮内瘤变(CIN)Ⅰ级的疗效。方法选取某院CINⅠ级合并高危HPV阳性患者80例(2016年6月~2018年6月),依据随机数字表法分组,每组40例。对照组采用重组人干扰素α-2b栓治疗,研究组在对照组基础上采用物理治疗。比较两组CINⅠ级治疗有效率、治疗后3个月、6个月、9个月HPV转阴率、治疗前后HPV病毒载量、血清炎性因子[白细胞介素-6(IL-6)、白细胞介素-2(IL-2)]水平。结果研究组CINⅠ级治疗有效率89.74%高于对照组71.79%(P<0.05);治疗后3个月、6个月、9个月,研究组HPV转阴率66.67%、82.05%、92.31%高于对照组25.64%、43.59%、53.85%(P<0.05);与对照组比较,治疗后研究组HPV病毒载量较少,血清IL-6、IL-2水平较低(P<0.05)。结论重组人干扰素α-2b栓联合物理治疗CINⅠ级合并高危HPV阳性患者,可提高CINⅠ级治疗有效率,减少HPV病毒载量,减轻炎症反应,提高HPV转阴率。     

保妇康栓联合干扰素栓对宫颈HPV感染患者HPV DNA负荷量、炎性因子及免疫功能的影响

目的分析保妇康栓联合干扰素栓对宫颈人乳头瘤病毒(HPV)感染患者HPV脱氧核糖核酸(HPV DNA)负荷量、炎性因子及免疫功能的影响。方法从2017年2月-2019年1月佛山市三水区人民医院收治的宫颈HPV感染患者中选取80例进行研究,以随机数字表法分为观察组和对照组,每组40例。对照组接受干扰素治疗,观察组在对照组基础上加用保妇康栓治疗,比较2组治疗效果及治疗前后HPV DNA负荷量、炎性因子及免疫功能指标。结果观察组治疗总有效率为95. 00%,高于对照组的80. 00%(P <0. 05);2组治疗前HPV DNA负荷量无明显差异(P>0. 05),观察组治疗后HPV DNA负荷量低于对照组(P <0. 05);2组治疗前高敏C-反应蛋白(hs-CRP)、降钙素原(PCT)、白介素-6(IL-6)水平无明显差异(P>0. 05),观察组治疗后炎性因子水平低于对照组(P <0. 05);2组治疗前CD3^+、CD4^+、CD8^+数值无明显差异(P> 0. 05),观察组治疗后上述免疫功能指标与对照组比较差异有统计学意义(P <0. 05)。结论保妇康栓联合干扰素栓可有效降低宫颈HPV感染患者HPV DNA负荷量,控制炎性因子水平,调节机体免疫功能,效果确切。     

Randomised comparative trial of the efficacy of paracetamol syrup and dispersible tablets for the treatment of fever in children

ObjectiveFever is the most common reason for the presentation of children in the outpatient department. Paracetamol is marketed in different formulations for ease of administration to the paediatric population. These include syrups, dispersible tablets and rectal inserts. Dispersible tablets disintegrate rapidly in liquid and are subsequently taken orally, providing another oral formulation. We determined if there is a difference in the antipyretic efficacy of the syrup and the dispersible formulation of paracetamol, thereby prompting the development of the latter (another oral formulation) for use in children.MethodsA randomised, controlled, double-blind intervention of a single dose of both formulations was given to febrile children, and their temperatures were documented twice in 30-minute intervals. Temperature changes were compared statistically.ResultsThe mean temperatures at recruitment were 38.2 ± 0.5°C and 38.3 ± 0.6°C for the dispersible and syrup group, respectively. There was no significant difference between the temperature changes at T2 (30 minutes) and T3 (60 minutes) between the two study arms. However, the temperature was significantly different at T1 (baseline), T2 and T3 within the dispersible and syrup groups.ConclusionThe decreasing trend in temperature was similar in both groups. Both preparations produced statistically similar antipyretic effects with no reported adverse drug reaction.     

酚氨咖敏颗粒质量标准研究

目的完善酚氨咖敏颗粒的质量标准。方法采用薄层色谱(TLC)法对乙酰氨基酚、氨基比林、咖啡因及马来酸氯苯那敏进行定性鉴别。采用气相色谱(GC)法同时测定4种成分的含量,色谱柱为TR-1弹性石英毛细管柱(30 m×0. 32 mm,0. 25μm),程序升温(起始温度为180℃,保持1 min,再以8℃/min的速率升至240℃,保持2 min),氢火焰离子化检测器温度为260℃。结果 TLC法可同时鉴别酚氨咖敏颗粒中4种成分。对乙酰氨基酚、氨基比林、咖啡因及马来酸氯苯那敏质量浓度线性范围分别为186. 3~5 960μg/m L(r=0. 999 9),124. 9~3 996μg/m L(r=0. 999 9),38. 24~1 224μg/m L(r=1. 000 0)和2. 525~80. 80μg/m L(r=0. 999 9);平均加样回收率分别为98. 69%,99. 45%,99. 52%,101. 40%,RSD分别为1. 36%,1. 62%,1. 20%,1. 25%(n=9)。结论该方法简便快速、准确可靠,适用于酚氨咖敏颗粒中4种成分的定性、定量分析,可更全面地控制该制剂的质量。     

壳聚糖活性炭栓预防宫颈术后并发症的临床价值

目的探讨壳聚糖活性炭栓对宫颈术后并发症的预防作用及其治疗宫颈病变的临床价值.方法选取宫颈病变行LEEP治疗或微波治疗的患者进行研究.行LEEP治疗480例,随机分为治疗组(240例)和对照组(240例),治疗组LEEP术后即开始给予壳聚糖活性炭栓阴道上药,共7 d,对照组不进行阴道上药,术后碘伏纱布阴道填塞24 h.微波治疗480例,随机分为治疗组(240例)和对照组(240例),治疗组微波治疗术后立即给予壳聚糖活性炭栓阴道上药,共7 d,对照组不进行阴道上药.结果无论是微波治疗还是LEEP治疗,治疗组在术后阴道流液时间、阴道流血量及持续时间方面均明显少于对照组,创面愈合情况优于对照组,创面愈合时间较对照组明显缩短(P<0.05).结论壳聚糖活性炭栓可以明显减少宫颈病变患者术后并发症的发生,缩短创面愈合时间,增加患者术后舒适度,具有显著的临床意义,值得临床推广.     

康复新液对HPV阳性宫颈糜烂患者转阴的临床效果研究

目的：观察康复新液对HPV阳性患者转阴的治疗作用。方法对门诊治疗的宫颈糜烂患者,给予HPV筛查,对筛查阳性的162例患者,随机分为研究组和对照组,研究组给予康复新液阴道用药治疗12个月,对照组给予保妇康栓阴道用药12个月,比较治疗效果和HPV转阴情况。结果研究组治疗效果明显好于对照组,治疗12个月时,痊愈61例(75．31%),好转11例(13．58%),无效9例(11．11%),有效率88．89%;对照组治疗12个月时,痊愈36例(44．44%),好转12例(14．81%),无效33例(40．74%),有效率59．26%。研究组转阴36例(44．44%),显著改善32例(39．51%),改善5例(6．17%),无改善8例(9．88%),升高0例(0．00%),改善率90．12%;对照组转阴21例(25．93%),显著改善22例(27．16%),改善6例(7．41%),无改善31例(38．27%),升高1例(1．23%),改善率60．49%。结论康复新液用于治疗HPV阳性宫颈糜烂患者,不仅有利于病情更好恢复,而且对HPV转阴有临床价值,因而对宫颈糜烂发生癌变有预防作用。     

The effect of intravenous paracetamol for the prevention of rocuronium injection pain

Rocuronium is a nondepolarizing neuromuscular blocking agent used in anesthesia induction and is associated with considerable discomfort and burning pain during injection, which is reported to occur in 50–80% of patients. This study was carried out to investigate the effectiveness of intravenous paracetamol pretreatment compared with lidocaine and normal saline to prevent rocuronium injection pain. The study included 150 ASA I–II patients undergoing elective orthopedic, gastrointestinal, and gynecological procedures under general anesthesia. They were allocated into three groups according to pretreatment drugs: lidocaine (40 mg) (n = 50), paracetamol (n = 50), and normal saline group (n = 50). Before anesthesia induction with propofol, all patients were pretreated with rocuronium. The pain caused by the injection was evaluated. Local signs were assessed on the arm at the end of the injection, as well as 24 hours after recovery from anesthesia. There were no patients with blurred speech or vision and there was no respiratory depression in any group after pretreatment with the study drug. The level of pain on injection was statistically lower in those who had received paracetamol compared to normal saline (p = 0.009). There were more patients in the saline group with severe pain (p < 0.001). Paracetamol relieved the rocuronium injection pain better than normal saline but lidocaine was the best of the three drugs (p < 0.001).     

Evaluation of hepatoprotective activity of alcoholic and aqueous extracts of Selaginella lepidophylla

ObjectiveTo screen Selaginella lepidophylla (S. lepidophylla) that are used in traditional medicine for their claimed hepatoprotective properties.MethodsAlcoholic and aqueous extracts of S. lepidophylla were evaluated for their hepatoprotective activity using CCl₄ and paracetamol induced acute hepatic injury model.ResultsTreatment with CCl₄ and paracetamol significantly increased liver weight and volume compared to the normal group. Pretreatment with silymarin alcoholic and aqueous extracts significantly prevent increase in liver weight and volume.ConclusionsFrom the present experimental study it can be concluded that alcoholic and aqueous extract of S. lepidophylla exhibited significant hepatoprotective activity against CCl₄ and paracetamol induced hepatotoxicity in rats, as result showed in physical, biochemical and histopathological parameters.